Home Categories API 9-Amino-1,2,3,4-tetrahydroacridine hydrochloride hydrate
A0805512

9-Amino-1,2,3,4-tetrahydroacridine hydrochloride hydrate , ≥99% , 1684-40-8

Synonym(s):
9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;Tacrine hydrochloride

CAS NO.:1684-40-8

Empirical Formula: C13H15ClN2

Molecular Weight: 234.72

MDL number: MFCD00012657

EINECS: 216-867-5

Pack Size Price Stock Quantity
1G RMB279.20 In Stock
5G RMB943.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 280-284 °C(lit.)
storage temp.  Inert atmosphere,2-8°C
solubility  Soluble in aqueous buffers
pka pKa 9.8 (Uncertain)
form  Crystalline solid
color  White to light yellow
CAS DataBase Reference 1684-40-8(CAS DataBase Reference)
EPA Substance Registry System Tacrine hydrochloride (1684-40-8)

Description and Uses

Tacrine is the first therapeutic launched specifically for the treatment of Alzheimer's disease which affects four million people in the US alone. Clinically significant improvement in cognition has been demonstrated in the patients with Alzheimer's disease. Although the cause of Alzheimer's disease is not understood, degeneration of cholinergic neurons is thought to be a primary factor in the development and progression of the disease. Tacrine is a reversible acetylcholinesterase inhibitor that presumably acts centrally by elevating the acetylcholine level in the cerebral cortex and by slowing degradation of acetylcholine from intact cholinergic neurons. While tacrine improves the symptoms of Alzheimer's disease, the underlining cause of the dementing process is not altered. It has also been suggested that the beneficial effects of tacrine may be due to its multiple effects on several neurotransmitter systems.

A potent centrally acting anticholinesterase, for therapy of memory deficits in patients with Alzheimers disease. THA also selectively blocks potassium channels in the central nervous system, which results in an increased release of acetylcholi

Safety

Symbol(GHS) 
GHS06
Signal word  Danger
Hazard statements  H302-H331-H301-H315-H319-H335
Precautionary statements  P305+P351+P338-P261-P280a-P304+P340-P405-P501a
Hazard Codes  T,Xn
Risk Statements  25-36/37/38-20/22
Safety Statements  26-36-45
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS  AR9532500
HazardClass  6.1(a)
PackingGroup  II
Toxicity LD50 intravenous in mouse: 5600ug/kg

RELATED PRODUCTS